chr15-50481590-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005154.5(USP8):​c.1328A>G​(p.Asp443Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0325 in 1,614,032 control chromosomes in the GnomAD database, including 1,316 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 91 hom., cov: 33)
Exomes 𝑓: 0.033 ( 1225 hom. )

Consequence

USP8
NM_005154.5 missense

Scores

1
12
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 7.38

Publications

23 publications found
Variant links:
Genes affected
USP8 (HGNC:12631): (ubiquitin specific peptidase 8) This gene encodes a protein that belongs to the ubiquitin-specific processing protease family of proteins. The encoded protein is thought to regulate the morphology of the endosome by ubiquitination of proteins on this organelle and is involved in cargo sorting and membrane trafficking at the early endosome stage. This protein is required for the cell to enter the S phase of the cell cycle and also functions as a positive regulator in the Hedgehog signaling pathway in development. Pseudogenes of this gene are present on chromosomes 2 and 6. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
USP8 Gene-Disease associations (from GenCC):
  • autosomal recessive spastic paraplegia type 59
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069358647).
BP6
Variant 15-50481590-A-G is Benign according to our data. Variant chr15-50481590-A-G is described in ClinVar as Benign. ClinVar VariationId is 458312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0888 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
USP8NM_005154.5 linkc.1328A>G p.Asp443Gly missense_variant Exon 11 of 20 ENST00000307179.9 NP_005145.3 P40818-1A0A024R5S4A8K8N5
USP8NM_001128610.3 linkc.1328A>G p.Asp443Gly missense_variant Exon 11 of 20 NP_001122082.1 P40818-1A0A024R5S4
USP8NM_001283049.2 linkc.1097A>G p.Asp366Gly missense_variant Exon 9 of 17 NP_001269978.1 P40818-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
USP8ENST00000307179.9 linkc.1328A>G p.Asp443Gly missense_variant Exon 11 of 20 1 NM_005154.5 ENSP00000302239.4 P40818-1

Frequencies

GnomAD3 genomes
AF:
0.0295
AC:
4487
AN:
152158
Hom.:
91
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0191
Gnomad AMI
AF:
0.00440
Gnomad AMR
AF:
0.0232
Gnomad ASJ
AF:
0.0213
Gnomad EAS
AF:
0.0959
Gnomad SAS
AF:
0.0762
Gnomad FIN
AF:
0.0351
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0290
Gnomad OTH
AF:
0.0210
GnomAD2 exomes
AF:
0.0354
AC:
8883
AN:
251158
AF XY:
0.0364
show subpopulations
Gnomad AFR exome
AF:
0.0162
Gnomad AMR exome
AF:
0.0247
Gnomad ASJ exome
AF:
0.0169
Gnomad EAS exome
AF:
0.0736
Gnomad FIN exome
AF:
0.0348
Gnomad NFE exome
AF:
0.0285
Gnomad OTH exome
AF:
0.0288
GnomAD4 exome
AF:
0.0328
AC:
47938
AN:
1461756
Hom.:
1225
Cov.:
31
AF XY:
0.0337
AC XY:
24498
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.0161
AC:
540
AN:
33468
American (AMR)
AF:
0.0244
AC:
1091
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0186
AC:
486
AN:
26132
East Asian (EAS)
AF:
0.131
AC:
5218
AN:
39682
South Asian (SAS)
AF:
0.0636
AC:
5480
AN:
86226
European-Finnish (FIN)
AF:
0.0330
AC:
1760
AN:
53410
Middle Eastern (MID)
AF:
0.0168
AC:
97
AN:
5764
European-Non Finnish (NFE)
AF:
0.0280
AC:
31190
AN:
1111966
Other (OTH)
AF:
0.0344
AC:
2076
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2556
5112
7667
10223
12779
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1226
2452
3678
4904
6130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0295
AC:
4494
AN:
152276
Hom.:
91
Cov.:
33
AF XY:
0.0311
AC XY:
2315
AN XY:
74458
show subpopulations
African (AFR)
AF:
0.0191
AC:
793
AN:
41554
American (AMR)
AF:
0.0234
AC:
357
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0213
AC:
74
AN:
3470
East Asian (EAS)
AF:
0.0958
AC:
496
AN:
5180
South Asian (SAS)
AF:
0.0750
AC:
362
AN:
4828
European-Finnish (FIN)
AF:
0.0351
AC:
373
AN:
10616
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0290
AC:
1972
AN:
68022
Other (OTH)
AF:
0.0260
AC:
55
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
223
446
669
892
1115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0301
Hom.:
434
Bravo
AF:
0.0254
TwinsUK
AF:
0.0326
AC:
121
ALSPAC
AF:
0.0314
AC:
121
ESP6500AA
AF:
0.0182
AC:
80
ESP6500EA
AF:
0.0264
AC:
227
ExAC
AF:
0.0362
AC:
4390
Asia WGS
AF:
0.127
AC:
440
AN:
3478
EpiCase
AF:
0.0274
EpiControl
AF:
0.0294

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.52
D;D;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.79
.;T;T
MetaRNN
Benign
0.0069
T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.0
M;M;.
PhyloP100
7.4
PrimateAI
Uncertain
0.48
T
PROVEAN
Uncertain
-3.3
D;D;D
REVEL
Uncertain
0.39
Sift
Uncertain
0.011
D;D;D
Sift4G
Uncertain
0.033
D;D;D
Polyphen
1.0
D;D;.
Vest4
0.61
ClinPred
0.0071
T
GERP RS
5.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.28
gMVP
0.27
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3743044; hg19: chr15-50773787; COSMIC: COSV56168864; API